Chen Lab
The Chen Lab focuses on cardiac arrhythmias, utilizing rabbit models to study the mechanisms of arrhythmogenesis. We also conduct clinical trials. The STALL-AF trial tests the hypothesis that subcutaneous nerve stimulation can control atrial fibrillation. The RAISE-BP trial tests the hypothesis that mirabegron, a beta-3 agonist, can raise blood pressure in patients with dysautonomia.
Personal Statement
I am a clinical cardiac electrophysiologist interested in understanding the mechanisms of cardiac fibrillation and defibrillation, as well as the importance of the autonomic nervous system in cardiac arrhythmogenesis.
Peng-Sheng Chen
Breakthrough Research
- Skin sympathetic nerve activity and cardiac arrhythmogenesis
- Subcutaneous nerve stimulation for controlling atrial fibrillation
- Using mirabegron, a beta-3 agonist, to raise blood pressure
- The association between mRNA vaccination and postural orthostatic tachycardia syndrome
Laboratory Team
Learn more about the scientists, faculty members, investigators, and other healthcare professionals of the Chen Lab, whose dedicated efforts lead to groundbreaking discoveries.
Job Opportunities
We are actively recruiting students and postdocs to be our colleagues and expand lab knowledge and expertise to make important breakthroughs.
Collaborations
The Chen Lab collaborates with a wide range of investigators within Cedars-Sinai and institutions around the world.